vs
Side-by-side financial comparison of KINGSTONE COMPANIES, INC. (KINS) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $56.4M, roughly 1.0× KINGSTONE COMPANIES, INC.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 34.0%). KINGSTONE COMPANIES, INC. produced more free cash flow last quarter ($73.1M vs $-167.0M).
Kingstone Companies, Inc., headquartered in Kingston, New York, provides property and casualty insurance products through its subsidiary, Kingstone Insurance Company. It places contracts with the third-party licensed premium finance company through its subsidiary Payments, Inc., a NYS licensed Insurance Premium Finance Company. Kingstone Insurance Company was ranked #1 of the 81 insurers rated by the Professional Insurance Agents Association in its 2010 Company Performance Survey. The company...
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
KINS vs PHAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $56.4M | $57.6M |
| Net Profit | $14.8M | — |
| Gross Margin | — | 86.7% |
| Operating Margin | 32.7% | — |
| Net Margin | 26.2% | — |
| Revenue YoY | 34.0% | 94.1% |
| Net Profit YoY | 171.4% | 71.6% |
| EPS (diluted) | $1.09 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.4M | $57.6M | ||
| Q3 25 | $55.7M | $49.5M | ||
| Q2 25 | $52.3M | $39.5M | ||
| Q1 25 | $50.5M | $28.5M | ||
| Q4 24 | $42.1M | $29.7M | ||
| Q3 24 | $40.8M | $16.4M | ||
| Q2 24 | $36.5M | $7.3M | ||
| Q1 24 | $35.8M | — |
| Q4 25 | $14.8M | — | ||
| Q3 25 | $10.9M | $-30.0M | ||
| Q2 25 | $11.3M | $-75.8M | ||
| Q1 25 | $3.9M | $-94.3M | ||
| Q4 24 | $5.4M | — | ||
| Q3 24 | $7.0M | $-85.6M | ||
| Q2 24 | $4.5M | $-91.4M | ||
| Q1 24 | $1.4M | — |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.1% | ||
| Q3 24 | — | 85.6% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | — | — |
| Q4 25 | 32.7% | — | ||
| Q3 25 | 24.6% | -30.8% | ||
| Q2 25 | 27.1% | -151.7% | ||
| Q1 25 | 9.3% | -276.5% | ||
| Q4 24 | 15.9% | — | ||
| Q3 24 | 22.3% | -433.0% | ||
| Q2 24 | 15.7% | -1055.4% | ||
| Q1 24 | 5.0% | — |
| Q4 25 | 26.2% | — | ||
| Q3 25 | 19.5% | -60.5% | ||
| Q2 25 | 21.5% | -191.9% | ||
| Q1 25 | 7.7% | -330.7% | ||
| Q4 24 | 12.9% | — | ||
| Q3 24 | 17.1% | -523.3% | ||
| Q2 24 | 12.4% | -1248.6% | ||
| Q1 24 | 4.0% | — |
| Q4 25 | $1.09 | — | ||
| Q3 25 | $0.74 | $-0.41 | ||
| Q2 25 | $0.78 | $-1.05 | ||
| Q1 25 | $0.27 | $-1.31 | ||
| Q4 24 | $0.44 | — | ||
| Q3 24 | $0.55 | $-1.32 | ||
| Q2 24 | $0.37 | $-1.56 | ||
| Q1 24 | $0.12 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $130.0M |
| Total DebtLower is stronger | $4.4M | $209.1M |
| Stockholders' EquityBook value | $122.7M | $-438.2M |
| Total Assets | $453.4M | $259.1M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $130.0M | ||
| Q3 25 | — | $135.2M | ||
| Q2 25 | — | $149.6M | ||
| Q1 25 | — | $212.3M | ||
| Q4 24 | — | $297.3M | ||
| Q3 24 | — | $334.7M | ||
| Q2 24 | — | $276.2M | ||
| Q1 24 | — | — |
| Q4 25 | $4.4M | $209.1M | ||
| Q3 25 | $4.8M | $207.1M | ||
| Q2 25 | $5.1M | $205.1M | ||
| Q1 25 | $5.4M | $203.2M | ||
| Q4 24 | $11.2M | $201.4M | ||
| Q3 24 | $17.3M | $175.7M | ||
| Q2 24 | $25.3M | $174.4M | ||
| Q1 24 | $25.3M | — |
| Q4 25 | $122.7M | $-438.2M | ||
| Q3 25 | $107.7M | $-422.5M | ||
| Q2 25 | $94.9M | $-405.8M | ||
| Q1 25 | $82.2M | $-338.4M | ||
| Q4 24 | $66.7M | $-253.6M | ||
| Q3 24 | $59.7M | $-187.1M | ||
| Q2 24 | $40.8M | $-233.8M | ||
| Q1 24 | $35.7M | — |
| Q4 25 | $453.4M | $259.1M | ||
| Q3 25 | $428.6M | $240.3M | ||
| Q2 25 | $393.4M | $250.2M | ||
| Q1 25 | $385.4M | $294.2M | ||
| Q4 24 | $374.9M | $378.3M | ||
| Q3 24 | $347.0M | $387.0M | ||
| Q2 24 | $319.8M | $319.4M | ||
| Q1 24 | $318.3M | — |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.05× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.17× | — | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.71× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.9M | $-166.8M |
| Free Cash FlowOCF − Capex | $73.1M | $-167.0M |
| FCF MarginFCF / Revenue | 129.5% | -290.0% |
| Capex IntensityCapex / Revenue | 5.0% | 0.4% |
| Cash ConversionOCF / Net Profit | 5.14× | — |
| TTM Free Cash FlowTrailing 4 quarters | $124.0M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.9M | $-166.8M | ||
| Q3 25 | $25.9M | $-14.1M | ||
| Q2 25 | $9.3M | $-62.7M | ||
| Q1 25 | $17.9M | $-84.9M | ||
| Q4 24 | $57.9M | $-266.8M | ||
| Q3 24 | $21.7M | $-63.6M | ||
| Q2 24 | $7.1M | $-70.7M | ||
| Q1 24 | $6.1M | — |
| Q4 25 | $73.1M | $-167.0M | ||
| Q3 25 | $25.3M | $-14.1M | ||
| Q2 25 | $8.7M | $-62.8M | ||
| Q1 25 | $17.0M | $-84.9M | ||
| Q4 24 | $55.6M | $-266.9M | ||
| Q3 24 | $21.0M | $-63.6M | ||
| Q2 24 | $6.6M | $-70.8M | ||
| Q1 24 | $5.6M | — |
| Q4 25 | 129.5% | -290.0% | ||
| Q3 25 | 45.4% | -28.6% | ||
| Q2 25 | 16.6% | -159.0% | ||
| Q1 25 | 33.7% | -297.9% | ||
| Q4 24 | 132.1% | -899.8% | ||
| Q3 24 | 51.6% | -389.0% | ||
| Q2 24 | 18.1% | -966.2% | ||
| Q1 24 | 15.5% | — |
| Q4 25 | 5.0% | 0.4% | ||
| Q3 25 | 1.2% | 0.1% | ||
| Q2 25 | 1.1% | 0.2% | ||
| Q1 25 | 1.7% | 0.1% | ||
| Q4 24 | 5.6% | 0.5% | ||
| Q3 24 | 1.7% | 0.3% | ||
| Q2 24 | 1.4% | 0.6% | ||
| Q1 24 | 1.5% | — |
| Q4 25 | 5.14× | — | ||
| Q3 25 | 2.38× | — | ||
| Q2 25 | 0.82× | — | ||
| Q1 25 | 4.60× | — | ||
| Q4 24 | 10.65× | — | ||
| Q3 24 | 3.12× | — | ||
| Q2 24 | 1.58× | — | ||
| Q1 24 | 4.27× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
